Workshop
CLIN
1. Maternal and Fetal Outcomes in the Era of CFTR Modulators (MAYFLOWERS) Study: Results of the CGM Sub-Study – Presented by Melissa S. Putman
2. Understanding Menopause in the Post-Modulator Era – Presented by Heidi Guzman
3. Effect of CFTR Modulator Therapy on the Risk of CF-Related Diabetes – Presented by Samar Atteih
4. Glycemia and Insulin Secretion Before and Four Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO Extension – Presented by Christine Chan
5. Genetic Determinants of Low Bone Mineral Density in Cystic Fibrosis – Presented by Arunan Selvarajah
Lina Merjaneh, MD
Baylor College of Medicine
Kevin J. Scully, MB BCh BAO
Hasbro Children's, Rhode Island Hospital; Warren Alpert Medical School of Brown University
Melissa Putman
Massachusetts General Hospital
Heidi Guzman
Columbia University
Samar E. Atteih, MB BCh BAO
Johns Hopkins University
Christine L. Chan
University of Colorado School of Medicine and Children's Hospital Colorado
Arunan Selvarajah, MSc
St Michael’s Hospital